1,731
Views
20
CrossRef citations to date
0
Altmetric
Original Article

Characterization of silver particles in the stratum corneum of healthy subjects and atopic dermatitis patients dermally exposed to a silver-containing garment

, , , , , , , , , , & show all
Pages 1480-1491 | Received 03 Mar 2016, Accepted 26 Jul 2016, Published online: 05 Oct 2016

References

  • Arbabi Bidgoli S, Mahdavi M, Rezayat SM, Korani M, Amani A, Ziarat I. 2013. Toxicity Assessment of Nanosilver Wound Dressing in Wistar Rat. Acta Medica Iranica 51:203–8
  • Ansari MA, Khan HM, Khan AA, Malik A, Sultan A, Shahid M, et al. 2011. Evaluation of antibacterial activity of silver nanoparticles against MSSA and MRSA on isolates from skin infections. Biol Med 3:141–6
  • Bianco C, Kezic S, Crosera M, Svetličić V, Šegota S, Maina G, et al. 2015. In vitro percutaneous penetration and characterization of silver from silver-containing textiles. Int J Nanomedicine 10:1899–908
  • Bronaugh RL, Stewart RF. 1985. Methods for in vitro percutaneous absorption studies V: permeation through damaged skin. J Pharm Sci 74:1062–6
  • Ercegović S, Ražić SE, Čunko R, Svetličić V, Šegota S. 2011. Application of AFM for identification of fibre surface changes after plasma treatments. Mat Technol 26:146–52
  • George R, Merten S, Wang TT, Kennedy P, Maitz P. 2014. In vivo analysis of dermal and systemic absorption of silver nanoparticles through healthy human skin. Australas J Dermatol 55:185–90
  • Impellitteri CA, Tolaymat TM, Scheckel KG. 2009. The speciation of silver nanoparticles in antimicrobial fabric before and after exposure to a hypochlorite/detergent solution. J Environ Qual 38:1528–30
  • Jain J, Arora S, Rajwade JM, Omray P, Khandelwal S, Paknikar KM. 2009. Silver nanoparticles in therapeutics: development of an antimicrobial gel formulation for topical use. Mol Pharm 6:1388–401
  • Jakasa I, Verberk MM, Bunge AL, Kruse J, Kezic S. 2006. Increased permeability for polyethylene glycols through skin compromised by sodium lauryl sulphate. Exp Dermatol 15:801–7
  • Jakasa I, Verberk MM, Esposito M, Bos JD, Kezic S. 2007. Altered penetration of polyethylene glycols into uninvolved skin of atopic dermatitis patients. J Invest Dermatol 127:129–34
  • Jensen LB, Petersson K, Nielsen HM. 2011. In vitro penetration properties of solid lipid nanoparticles in intact and barrier-impaired skin. Eur I. Eur J Pharm Biopharm 79:68–75
  • Keck CM, Schwabe K. 2009. Silver-nanolipid complex for application to atopic dermatitis skin: rheological characterization, in vivo efficiency and theory of action. J Biomed Nanotechnol 5:428–36
  • Keck CM, Anantaworasakul P, Patel M, Okonogi S, Singh KK, Roessner D, et al. 2014. A new concept for the treatment of atopic dermatitis: silver-nanolipid complex (sNLC). Int J Pharm 462:44–51
  • Kezic S, Nielsen JB. 2009. Absorption of chemicals through compromised skin. Int Arch Occup Environ Health 82:677–88
  • Kim KJ, Sung WS, Moon SK, Choi JS, Kim JG, Lee DG. 2008. Antifungal effect of silver nanoparticles on dermatophytes. J Microbiol Biotechnol 18:1482–4
  • Korani M, Ghazizadeh E, Korani SH, Hami Z, Mohammadi- Bardbori A. 2015. Effects of silver nanoparticleson human health. Eur. J. Nanomed 7:51–62
  • Korani M, Rezayat SM, Gilani K, Arbabi Bidgoli S, Adeli S. 2011. Acute and subchronic dermal toxicity of nanosilver in guinea pig. Int J Nanomed 6:855–62
  • Labouta HI, El-Khordagui LK, Krausc T, Schneider M. 2011. Mechanism and determinants of nanoparticle penetration through human skin. Nanoscale 3:4989–99
  • Lademann J, Jacobi U, Surber C, Weigmann HJ, Fluhr JW. 2009. The tape stripping procedure – evaluation of some critical parameters. Eur J Pharm Biopharm 72:317–23
  • Lademann J, Richter H, Teichmann A, Otberg N, Blume-Peytavia U, Luengob J, et al. 2007. Nanoparticles—an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm 66:159–64
  • Larese FF, D’Agostin F, Crosera M, Adami G, Renzi N, Bovenzi M, Maina G. 2009. Human skin penetration of silver nanoparticles through intact and damaged skin. Toxicology 255:33–7
  • Lieb LM, Ramachandran C, Egbaria K, Weiner N. 1992. Topical delivery enhancement with multilamellar liposomes into pilosebaceous units: I. In vitro evaluation using fluorescent techniques with the hamster ear model. J Invest Dermatol 99:108–13
  • Liu J, Sonshine DA, Shervani S, Hurt RH. 2010. Controlled release of biologically active silver from nanosilver surfaces. ACS Nano 4:6903–13
  • Loeschner K, Hadrup N, Qvortrup K, Larsen A, Gao X, Vogel U, et al. 2011. Distribution of silver in rats following 28 days of repeated oral exposure to silver nanoparticles or silver acetate. Part Fibre Toxicol 8:18
  • Martinez-Castanon GA, Nino-Martinez N, Martinez-Gutierrez F, Martinez-Mendoza JR, Ruiz F. 2008. Synthesis and antibacterial activity of silver nanoparticles with different sizes. J Nanopart Res 10:1343
  • Massi D, Santucci M. 1998. Human generalized argyria: a submicroscopic and X-ray spectroscopic study. Ultrastruct Pathol 22:47–53
  • Mohammed D, Yang Q, Guy RH, Matts PJ, Hadgraft J, Lane ME. 2012. Comparison of gravimetric and spectroscopic approaches to quantify stratum corneum removed by tape-stripping. Eur J Pharm Biopharm 82:171–4
  • Oriňáková R, Škantárová L, Oriňák A, Demko J, Kupková M, Andersson JT. 2013. Electrochemical deposition of SERS active nanostructured silver films. Int J Electrochem Sci 8:80–99
  • Pletikapić G, Žutić V, Vinković Vrček I, Svetličić V. 2012. Atomic force microscopy characterization of silver nanoparticles interactions with marine diatom cells and extracellular polymeric substance. J Mol Recognit 25:309–17
  • Pluut O, Bianco C, Jakasa I, Visser MI, Krystek P, Larese-Filon F, et al. 2015. Percutaneous penetration of silver from a silver containing garment in healthy volunteers and patients with atopic dermatitis. Tox Lett 235:116–22
  • Prow TW, Grice JE, Lin LL, Faye R, Butler M, Becker W, et al. 2011. Nanoparticles and microparticles for skin drug delivery. Adv Drug Deliv Rev 63:470–91
  • R Core Team. 2013. A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. Available at: http://www.R-project.org/
  • Rigo C, Ferroni L, Tocco I, Roman M, Munivrana I, Gardin C, et al. 2013. Active silver nanoparticles for wound healing. Int J Mol Sci 14:4817–40
  • Schaefer H, Lademann J. 2001. The role of follicular penetration. A differential view. Skin Pharmacol Appl Skin Physiol 14:23–7
  • Stefaniak AB, Duling MG, Lawrence RB, Thomas TA, LeBouf RF, Wade EE, Virji MA. 2014. Dermal exposure potential from textiles that contain silver nanoparticles. Int J Occup Environ Health 20:220–34
  • Trop M, Novak M, Rodl S, Hellbom B, Kroell W, Goessler W. 2006. Silver-coating dressing acticoat caused raised liver enzymes and argyria-like symptoms in burn patient. J Trauma 60:648–52
  • van der Zande M, Vandebriel RJ, Van Doren E, Kramer E, Rivera ZH, Serrano-Rojero CS, et al. 2012. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 6:7427–42
  • Vlachou E, Chipp E, Shale E, Wilson YT, Papini R, Moiemen NS. 2007. The safety of nanocrystalline silver dressings on burns: a study of systemic silver absorption. Burns 33:979–85
  • Wang XQ, Chang HE, Francis R, Olszowy H, Liu P-Y, Kempf M, et al. 2009. Silver deposits in cutaneous burn scar tissue is a common phenomenon following application of a silver dressing. J Cutan Pathol 36:788–92
  • Watkinson AC, Bunge AL, Hadgraft J, Lane ME. 2013. Nanoparticles do not penetrate human skin - a theoretical perspective. Pharm Res 30:1943–6
  • Zhu Y, Choe C-S, Ahlberg S, Meinke MC, Alexiev U, Lademann J, Darwin ME. 2015. Penetration of silver nanoparticles into porcine skin ex vivo using fluorescence lifetime imaging microscopy, Raman microscopy, and surface-enhanced Raman scattering microscopy. J Biomed Opt 20:051006